A bio-orthogonally engineered probiotic-T cell chimera amplifies adoptive cell therapy through spatial DC-T cell immune licensing.

Shen J, Chu Y, Wang Y, Chen X, Ke Y, Huo D, Zhu J, Hong S, Qin S, Liu B, Liu Q

Open source

DOI
10.1016/j.scib.2026.09.009
Published
2026 Sep 4
Container
Science bulletin
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.scib.2026.09.009,
  title = {A bio-orthogonally engineered probiotic-T cell chimera amplifies adoptive cell therapy through spatial DC-T cell immune licensing.},
  author = {Shen J and Chu Y and Wang Y and Chen X and Ke Y and Huo D and Zhu J and Hong S and Qin S and Liu B and Liu Q},
  year = {2026},
  journal = {Science bulletin},
  doi = {10.1016/j.scib.2026.09.009},
  url = {https://doi.org/10.1016/j.scib.2026.09.009}
}

RIS

TY  - JOUR
TI  - A bio-orthogonally engineered probiotic-T cell chimera amplifies adoptive cell therapy through spatial DC-T cell immune licensing.
AU  - Shen J
AU  - Chu Y
AU  - Wang Y
AU  - Chen X
AU  - Ke Y
AU  - Huo D
AU  - Zhu J
AU  - Hong S
AU  - Qin S
AU  - Liu B
AU  - Liu Q
PY  - 2026
JO  - Science bulletin
DO  - 10.1016/j.scib.2026.09.009
UR  - https://doi.org/10.1016/j.scib.2026.09.009
ER  - 

APA

J, S., Y, C., Y, W., X, C., Y, K., D, H., J, Z., S, H., S, Q., B, L., & Q, L. (2026). A bio-orthogonally engineered probiotic-T cell chimera amplifies adoptive cell therapy through spatial DC-T cell immune licensing.. Science bulletin. https://doi.org/10.1016/j.scib.2026.09.009

Source records